ACCENDRA HEALTH INC/VA/·4

Mar 10, 9:02 PM ET

Leon Jonathan A 4

4 · ACCENDRA HEALTH INC/VA/ · Filed Mar 10, 2026

Research Summary

AI-generated summary of this filing

Updated

Accendra Health (ACH) EVP/CFO Leon Jonathan Receives Award

What Happened

  • Leon Jonathan A, EVP & Chief Financial Officer of Accendra Health (ACH), was granted 85,067 restricted shares on 2026-03-09. The shares were issued at $0.00 (no cash paid); total reported acquisition value $0. This transaction is an award (Form 4 code A), not an open‑market purchase or sale.

Key Details

  • Transaction date: 2026-03-09; filing date: 2026-03-10.
  • Shares granted: 85,067 restricted shares; price per share reported: $0.00; total reported value: $0.
  • Vesting: Grant vests one‑third per year over three years (footnote).
  • Shares owned after the transaction: Not specified in the information provided on this Form 4.
  • No indication of a 10b5‑1 plan, tax withholding, or immediate sale in the filing.
  • Filing appears timely (filed the day after the transaction).

Context

  • Restricted stock grants are commonly used for executive compensation and retention; they typically vest over time and align executives’ interests with shareholders but do not by themselves indicate a buy or sell sentiment.
  • Because this was an award (no cash paid and no immediate sale), there was no immediate change to market float from this transaction.

Insider Transaction Report

Form 4
Period: 2026-03-09
Transactions
  • Award

    Common Stock

    [F1]
    2026-03-09+85,067303,589 total
Footnotes (1)
  • [F1]Restricted stock grant which vests one-third per year over three years.
Signature
Jonathan A. Leon, by Rosemarie W. France POA|2026-03-10

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES